Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRemoved the 'Interstitial lung disease 2' term and the 'Genetic and Rare Diseases Information Center' entry under Resources.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check23 days agoChange DetectedUpdated the site revision to v3.4.3; the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedFooter updated to Revision: v3.4.2. The prior government funding/operating status notice (Revision: v3.4.1) has been removed.SummaryDifference0.5%

- Check58 days agoChange DetectedThe page update mainly adds a government funding notice and a new version label (v3.4.1), which are global site notices and do not modify study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check66 days agoChange DetectedThe page adds a glossary display toggle and new metadata lines such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removes 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.